[1]
Destiani, D.P., Milanda, T., Susilawati, S., Suwantika, A.A., Pradipta, I.S., Halimah, E., Diantini, A., Sumiwi, S.A., Muhtadi, A., Subarnas, A., Lestari, K. and Abdulah, R. 2017. COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-LEVOFLOXACIN AND CEFOTAXIME-ERYTHROMYCIN AS EMPIRICAL ANTIBIOTIC COMBINATIONS IN RESPIRATORY INFECTION-INDUCED SEPSIS. Asian Journal of Pharmaceutical and Clinical Research. 10, 14 (May 2017), 119–121. DOI:https://doi.org/10.22159/ajpcr.2017.v10s2.19515.